In this population-based analysis of trends in hospitalisation for infection among people with diabetes in Hong Kong, we report four major observations. First, rates of hospitalisation were stagnant for the majority of infection types and have increased for influenza in people with diabetes. Second, there was an age differential in the trends for hospitalisation for infection. In the young to middle-aged groups, hospitalisation rates for most infection types increased or remained unchanged, while in the older age groups, infection rates tended to decline over time. Third, the trends observed among people with diabetes were largely similar to people without diabetes in Hong Kong. Fourth, rates of hospitalisation for all infection types remained consistently higher in people with vs without diabetes throughout the observation period, and the relative differences in rates were the widest in the youngest age group and smallest in the oldest age group.
Unchanged or increasing rates of hospitalisation for common diabetes-related infections
People with diabetes are more prone to develop infections because diabetes is associated with other conditions, such as obesity, peripheral sensory neuropathy, chronic kidney disease, peripheral artery disease, stroke and congestive heart failure, that are independent risk factors for infection [11, 12]. Several studies have also identified blood glucose control as a risk determinant for hospital admission with an infective cause, independent of confounders including age, smoking and comorbidities [4, 11, 18]. In many developed regions, including Hong Kong, the rates of diabetes-related morbidities have fallen dramatically in the past 10–20 years, driven by improvements in blood glucose control and progresses in medical care [13,14,15]. It is therefore surprising to find static or even increasing rates of hospitalisation for common infection types despite declining prevalence of upstream risk factors. In the present study, rates of hospitalisation for infections of the skin, musculoskeletal system and kidney remained unchanged from 2001 to 2016, with increasing trends for sepsis after 2006/2007. Over a comparable study period between 2000 and 2015, population surveillance conducted in the USA detected increasing rates of hospitalisation for these infection types in people with diabetes [2]. The reason for the divergent trends of kidney infection and urinary tract infection is unclear, but it is possible that the increasing tendency to treat less-severe urinary tract infection in the outpatient setting could contribute to these observations. Discrepancies in coding could also account for the differences. Overall, our results suggest that the achieved improvements in blood glucose and other risk factors might not have been sufficient to prevent infection and progression to adverse outcome. Diabetes education covers various aspects of foot care to prevent foot infection but measures to reduce the risks of other clinically important infections might not have been adequately addressed.
Infection rates are influenced by other factors, such as changing pathogenicity of the infectious agents, development of resistance to antimicrobial drugs, public health measures and clinical practices, that apply to the entire population irrespective of diabetes status. In the present study, people with and without diabetes experienced marked decline in hospitalisation for tuberculosis, reflecting the successes of public health measures and medical treatment, although the relative difference in rates of tuberculosis between people with and without diabetes has not changed over time. Similarly, the rate ratios of hospitalisation due to kidney infection or sepsis by diabetes status have remained constant or even increased. In the study in the USA, a rise in the rate ratios for these infection types as well as infections of the skin and musculoskeletal system were also found [2]. Sustained risk differential indicates that the increased risks of serious infection in people with diabetes were unaltered by advances in diabetes therapeutics and that much room exists to narrow the gap in infection rates between people with and without diabetes.
Trends in rates of hospitalisation for pneumonia and influenza
The trends in hospitalisation for pneumonia and influenza deserve further consideration. We detected an increase in rates of hospitalisation for pneumonia from 2001 to 2004/2005, after which the rates decreased in men and were unchanged in women. In early- to mid-2003, Hong Kong experienced the SARS epidemic, in which 1750 local residents were infected with the coronavirus and 286 people died [19]. An increase in health awareness among the general population and a lower medical threshold for hospital admission during the immediate post-SARS period most likely explain the spike in rates of hospitalisation for pneumonia in 2004/2005. Stabilisation in rates thereafter could be partly attributed to measures taken by the local health authority to improve cleanliness of housing estates and districts, as well as widespread campaigns to promote personal hygiene [19]. Stabilisation in rates for pneumonia was also noted in people without diabetes and, contrary to other common infection types, the relative difference in rates between people with and without diabetes diminished during the study period. The reasons are unclear but more liberal use of renin–angiotensin–aldosterone system inhibitors and statins, which have been shown to lower the risks of pneumonia, among people with diabetes might contribute to these observations [20, 21].
In contrast to the stable trends for pneumonia, we observed rising trends in hospitalisation for influenza in people with and without diabetes. Diabetes is associated with a greater hazard of severe influenza [22, 23]. International guidelines recommend annual vaccination against influenza in people with diabetes [24], although whether people with diabetes derive the same level of protection as do people without diabetes remains inconclusive [25]. The Hong Kong Government influenza vaccination programme launched in 2004 prioritised free or subsidised immunisation to all people with diabetes [26]. Despite widespread promotion of the programme, only 12% of the general population were vaccinated in the most recent survey in 2015/16, although we have no information on the vaccination rates in people with diabetes [27]. The dramatic increase in annual rates of hospitalisation for influenza in both people with and without diabetes in Hong Kong could reflect increases in transmissibility and pathogenicity of the virus, compounded by increasing population density and overcrowding. Changes in clinical practice, in particular more frequent testing for influenza in people presenting with respiratory tract symptoms, could also explain the escalating trend.
Age differential in trends of hospitalisation for infection
In the present study, we found that rates of hospitalisation for most infections decreased in the older age groups (aged ≥65 years) but were stable or increased among the young and middle-aged groups. Our results are consistent with the study in the USA, which reported rising trends for hospitalisation rates for many infection types in the younger age groups (aged 18–44 years) with diabetes despite the decline in their older counterparts [2]. The lack of improvement shown in trends in the young people is evident across a range of diabetes-related complications and mortality rates in earlier analyses [17, 28]. Young people with diabetes have higher blood glucose levels than older people due to a combination of poorer treatment adherence and therapeutic inertia [29]. Young people also tend to delay seeking medical care, leading to more severe and clinically advanced presentation of medical conditions including infection. It is conceivable that these health-compromising behaviours of young people has not changed significantly over time, and that current approaches to managing diabetes have not been effective in improving health indices in this group. The differential infection risk associated with diabetes in younger vs older age groups is likely due to the lower background rates among the young general population. Nonetheless, the three- to fourfold increase in rates of hospitalisation for pneumonia, sevenfold increase in rates for tuberculosis, and six- to 11-fold increase in rates for generalised sepsis in young people with diabetes aged 20–44 years relative to their age-matched counterparts without diabetes highlights the unmet needs in these young individuals and calls for focused preventive strategies.
Limitations
This study has several limitations. First, the HKDSD comprises people who attended public hospitals and clinics operated by the HKHA and does not include people who presented to the private health sector. The HKHA covers about 95% of health services in Hong Kong and the exclusion of the small proportion of people with diabetes treated in private should have minimal impact on trend estimates. Second, the HKDSD is an administrative database subjected to issues of validity. For instance, people who were prescribed glucose-lowering drugs, such as metformin, for conditions other than diabetes could be included although the number is deemed small. Furthermore, we could not differentiate type 1 diabetes from type 2 diabetes in the HKDSD, although over 98% of Hong Kong Chinese with diabetes have type 2 diabetes [30]. Third, the increasing number of people with newly diagnosed diabetes each year could affect the trend estimates. In the sensitivity analysis, excluding those newly included in the HKDSD each study year did not yield any significant difference in the trends of infection-related hospitalisation. Fourth, we relied on diagnostic codes listed as principal diagnosis for event count and infections recorded as a secondary diagnosis were not included, leading to potential under-estimation of event rates. This limited the scope of the study to evaluate the trends in rates of nosocomial infections, which are more likely to be entered as secondary diagnosis. Fifth, people with diabetes could be more readily admitted to hospital than people without diabetes due to the greater care-seeking tendency of the former group and lower threshold for admitting people with chronic diseases such as diabetes. Trend estimates could be affected if the hospitalisation threshold has changed significantly over time. This was evident for hospitalisation for pneumonia around the time of the SARS epidemic. Sixth, data for hospital admission of people without diabetes were not available before 2007 and the available data only captured hospitalisation for a limited range of infection diagnoses. The comparison of rates between people with and without diabetes across the full surveillance period was not possible, resulting in a significantly shorter time period for trend analysis. Seventh, analysis of people without diabetes was based on aggregate data. In addition, different ICD coding systems were used to identify infection-related hospitalisation in people with diabetes and in people without diabetes. This would have affected the estimates of incidence rate ratios, although our estimates are similar to figures reported by others. Last, the study described the trends in Hong Kong and results may not be generalisable to other regions.
Conclusions
We observed unchanged or increasing rates of hospitalisation for most types of diabetes-related infection, except for decline in rates for tuberculosis and urinary tract infection, among people with diabetes in Hong Kong over a 16-year period. Improvements in diabetes care have not translated to narrowing of relative differences in rates of hospitalisation for most infection types when comparing people with and without diabetes during this time. The recent COVID-19 global outbreak has revealed the toll of diabetes and other chronic diseases on the healthcare system during acute emergencies. Greater efforts directed towards infection prevention and control in people with diabetes are urgently needed to reduce their risks of developing and progressing to serious infections.